Fredun Pharmaceuticals Limited has announced a board meeting on Thursday, 25th September 2025, to consider a proposal for issuing equity shares and/or warrants via a preferential allotment. This potential capital raising initiative could support the company's operations or growth plans. Shareholders should note that a preferential allotment might lead to some dilution. Additionally, the trading window for company insiders is currently closed and will reopen 48 hours after the meeting concludes.